103 related articles for article (PubMed ID: 3499970)
1. Natural killer cells in children with acute leukemia. The effect of interleukin-2.
Mageed AA; Findley HW; Franco C; Singhapakdi S; Alvarado C; Chan WC; Ragab AH
Cancer; 1987 Dec; 60(12):2913-8. PubMed ID: 3499970
[TBL] [Abstract][Full Text] [Related]
2. Recombinant interleukin-2 activates peripheral blood lymphocytes from children with acute leukemia to kill autologous leukemic cells.
Findley HW; Abdel Mageed A; Nasr SA; Ragab AH
Cancer; 1988 Nov; 62(9):1928-31. PubMed ID: 3262410
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-alpha and interleukin-2 on natural killer cell function against tumor cell lines.
Alvarado CS; Findley HW; Chan WC; Hnath RS; Abdel-Mageed A; Pais RC; Kutner MH; Ragab AH
Cancer; 1989 Jan; 63(1):83-9. PubMed ID: 2783377
[TBL] [Abstract][Full Text] [Related]
4. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
5. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
Lotzová E; Savary CA; Herberman RB
J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
[TBL] [Abstract][Full Text] [Related]
6. High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
Uharek L; Zeis M; Glass B; Steinmann J; Dreger P; Gassmann W; Schmitz N; Müller-Ruchholtz W
Leukemia; 1996 Nov; 10(11):1758-64. PubMed ID: 8892679
[TBL] [Abstract][Full Text] [Related]
7. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
[TBL] [Abstract][Full Text] [Related]
8. Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2.
Kay NE; Zarling J
Am J Hematol; 1987 Feb; 24(2):161-7. PubMed ID: 3028132
[TBL] [Abstract][Full Text] [Related]
9. Immunologic and clinical aspects of natural killer cells in human leukemia.
Lotzová E; Savary CA; Pollock RE; Fuchshuber P
Nat Immun Cell Growth Regul; 1990; 9(3):173-81. PubMed ID: 2370877
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of purified Leu 19+ cells from the peripheral blood of children with acute lymphocytic leukemia.
Afify ZA; Abdel-Mageed A; Findley HW; Ragab AH
Cancer; 1990 Aug; 66(3):469-73. PubMed ID: 1694716
[TBL] [Abstract][Full Text] [Related]
11. Altered natural killer cell activity in childhood acute non-lymphoid leukaemia. Augmented natural killer cell activity and cells expressing the Leu 7 and Leu 11b (CD 16) markers in the bone marrow of children in remission.
Sørskaar D; Førre O; Tjønneland S; Lie SO
Scand J Immunol; 1988 Jul; 28(1):11-7. PubMed ID: 3261034
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of human cord blood natural killer cells is enhanced by recombinant interleukin-15.
Saghafi S; Pourfathollah AA; Kheirandish M; Azimdoust A; Behnia M; Shahjahani M; Moin M
Iran J Allergy Asthma Immunol; 2010 Jun; 9(2):69-77. PubMed ID: 20683100
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
[TBL] [Abstract][Full Text] [Related]
14. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia.
Sørskaar D; Førre O; Lie SO
Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia.
Tajima F; Kawatani T; Endo A; Kawasaki H
Leukemia; 1996 Mar; 10(3):478-82. PubMed ID: 8642865
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
Kaufmann Y; Levanon M; Davidsohn J; Ramot B
J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
[TBL] [Abstract][Full Text] [Related]
17. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study.
Uchiyama T; Sato N; Narita M; Yamahira A; Iwabuchi M; Furukawa T; Sone H; Takahashi M
Hematol Oncol; 2013 Sep; 31(3):156-63. PubMed ID: 23108877
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
Chang WC; Hsiao MH; Pattengale PK
Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
[TBL] [Abstract][Full Text] [Related]
19. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
20. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
Klingemann HG; Wong E; Maki G
Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]